Targeting MDSC-HTR2B to Improve Immune Checkpoint Inhibitors in Breast to Brain Metastasis
M. Iyer, D. Das, A. Baugh, P. Shah, B. Nakamura, S. Sedighi, M. Reed, J. Jang, F. Chow, E. R. Torres, J. Neman
The paper identifies HTR2B on MDSCs as a target to enhance immune checkpoint inhibitors in breast-to-brain metastasis using clozapine and anti-PD-1 therapy.
bioRxiv · Jun 20, 2024 · PreprintCancer Biology